We are live on
!
Find out more
RBF Capital Portfolio holdings
AUM
$2.41B
Turnover
12.01%
1-Year Est. Return
39.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.75%
1 Year Est. Return
+39.41%
3 Year Est. Return
+146.98%
5 Year Est. Return
+207.22%
10 Year Est. Return
+1,174.87%
AUM
$766M
AUM Growth
-$156M
(-17%)
Cap. Flow
-$18.9M
Cap. Flow
% of AUM
-2.47%
Top 10 Holdings %
Top 10 Hldgs %
34.89%
Holding
469
New
57
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
3.2
years
Top 20 Avg Time Held Equity + Options
3.3
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
3.2
years
Top 20 Avg Time Held Equity only
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$6.88M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.95M |
| 3 |
Nabors Industries
NBR
|
+$4.26M |
| 4 |
Northern Trust
NTRS
|
+$2.81M |
| 5 |
JELD-WEN Holding
JELD
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$9.52M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.29M |
| 3 |
Dell
DELL
|
+$4.19M |
| 4 |
Amazon
AMZN
|
+$4.01M |
| 5 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.67% |
| 2 | Consumer Discretionary | 12.45% |
| 3 | Miscellaneous | 11.9% |
| 4 | Industrials | 8.94% |
| 5 | Healthcare | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EVOL
401
DELISTED
Evolving Systems, Inc.
EVOL
| $29K | ﹤0.01% |
24,496
| – | – |
2015 Q4
12 quarters
|
|
|
ALR
402
DELISTED
AlerisLife Inc
ALR
| $26K | ﹤0.01% |
5,502
-22,064
| -80% | -$129K |
2013 Q2
22 quarters
|
|
|
SIOX
403
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $24K | ﹤0.01% |
3,000
| – | – |
2018 Q2
2 quarters
|
|
|
TOO
404
DELISTED
Teekay Offshore Partners L.P.
TOO
| $24K | ﹤0.01% |
+20,000
| New | +$37K |
2018 Q4
0 quarters
|
|
|
SRRA
405
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $22K | ﹤0.01% |
411
| – | – |
2017 Q1
7 quarters
|
|
|
HSTO
406
DELISTED
Histogen Inc. Common Stock
HSTO
| $22K | ﹤0.01% |
65
| – | – |
2018 Q2
2 quarters
|
|
|
FRTX
407
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $16K | ﹤0.01% |
42
| – | – |
2016 Q4
8 quarters
|
|
408
Aptevo Therapeutics
APVO
$2.93M
| – | – |
0
| – | – |
2016 Q3
9 quarters
|
|
409
ATA Creativity
AACG
$27.4M
| $10K | ﹤0.01% |
10,427
| – | – |
2018 Q3
1 quarter
|
|
|
ADXS
410
DELISTED
Advaxis Inc
ADXS
| $6K | ﹤0.01% |
2,020
| – | – |
2018 Q2
2 quarters
|
|
411
SCYNEXIS
SCYX
$35.7M
| $5K | ﹤0.01% |
139
| – | – |
2016 Q3
9 quarters
|
|
412
Acco Brands
ACCO
$416M
| – | – |
-10,000
| Closed | -$113K | – |
|
413
Analog Devices
ADI
$192B
| – | – |
-10,000
| Closed | -$925K | – |
|
|
414
Amazon
AMZN
$2.69T
| – | – |
-40,000
| Closed | -$4.01M | – |
|
415
Apogee Enterprises
APOG
$867M
| – | – |
-5,000
| Closed | -$207K | – |
|
416
Ares Capital
ARCC
$13.4B
| – | – |
-80,000
| Closed | -$1.38M | – |
|
417
Broadcom
AVGO
$1.57T
| – | – |
-25,000
| Closed | -$617K | – |
|
418
Neighborhood Intelligence Inc
NXH
$172M
| – | – |
-31,550
| Closed | -$657K | – |
|
419
Conagra Brands
CAG
$6.9B
| – | – |
-50,000
| Closed | -$1.7M | – |
|
420
Comcast
CMCSA
$77.7B
| – | – |
-12,000
| Closed | -$425K | – |
|
421
Centene
CNC
$34.2B
| – | – |
-49,760
| Closed | -$3.6M | – |
|
|
422
Dell
DELL
$291B
| – | – |
-153,818
| Closed | -$4.19M | – |
|
423
DXC Technology
DXC
$2.17B
| – | – |
-2,959
| Closed | -$277K | – |
|
424
First Financial Bancorp
FFBC
$3.31B
| – | – |
-6,937
| Closed | -$206K | – |
|
425
GE Aerospace
GE
$326B
| – | – |
-5,008
| Closed | -$271K | – |
|
Similar funds
CI
LMC
RBF Capital's Q4 2018 Portfolio in Review
As of Q4 2018, RBF Capital held 469 positions worth $766M, down 17% from $922M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
RBF Capital's Q4 2018 filing shows 57 new, 31 increased, 55 reduced and 58 closed positions. Its largest new stake was Marathon Petroleum: 100,864 shares worth $5.95M. The largest sale was Andeavor, an estimated $9.52M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
- RBF Capital's largest Q4 2018 buy was Marathon Petroleum: 100,864 shares worth $5.95M.
- RBF Capital added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $5.95M increase.
- RBF Capital's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.29M.
- RBF Capital fully exited Andeavor in Q4 2018, selling an estimated $9.52M.
- RBF Capital's ten largest holdings make up 35% of its $766M portfolio in Q4 2018.
- RBF Capital opened 57 new positions and closed 58 in Q4 2018.
- RBF Capital's portfolio value fell 17% quarter-over-quarter to $766M.
Based on RBF Capital's 13F filing for Q4 2018, filed 14 Feb 2019.